Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy

5 May 2014

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to Lysosomal Storage Disorders Research
Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 24797185
DOI: 10.1038/bmt.2014.93

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophyPMID 24797185Read ↗

Metachromatic leukodystrophy: Disease spectrum and approaches for treatmentSemantic proximity Read ↗

Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.Semantic proximity Read ↗

[Metachromatic leukodystrophy].Semantic proximity Read ↗

The occurrence subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: An in vitro studySemantic proximity Read ↗

The Role of the Immune System in Myelodysplasia: Implications for TherapySemantic proximity Read ↗

Recent Advancements in the Diagnosis and Treatment of LeukodystrophiesSemantic proximity Read ↗

Ras and myelodysplasia: lessons from the last decade.Semantic proximity Read ↗

Recent advances in haematology.Semantic proximity Read ↗

T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone.Semantic proximity Read ↗

Clonal hematopoiesis and differential outcomes after immune checkpoint blockadeSemantic proximity Read ↗

Do we have to kill the last CML cell?Semantic proximity Read ↗

Immune effector cell-associated haematotoxicity after CAR T-cell therapy: from mechanism to managementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.